#1 Clinical Trials Search in Europe
Verified
High Ratings
80+ Specializations
210+ Therapies
Research Phase I/II/III

About Specializations

Wojskowy Instytut Medyczny Panstwowy Instytut Badawczy in Warsaw specializes in nuclear medicine and clinical trials in cancer, heart, lung, and immune diseases.

Medical Center localisation

Ul. Szaserow 128
04-141 Warsaw, Poland

Want to learn more about this study or check if you can participate? Contact us.

Ongoing studies

  • A Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies

    Recruiting

    2 1
    Investigated Diseases:
    France Germany Italy Poland Spain

  • A Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity

    Recruiting

    4 1
    Investigated Diseases:
    Belgium France Hungary Poland Romania Spain

  • Study of GSK5764227 alone and in combination for patients with previously treated advanced gastrointestinal tumors that cannot be removed by surgery or have spread

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Finland France Germany Italy The Netherlands +4

  • Study of Lutetium-177-DOTA-TATE with octreotide LAR in newly diagnosed patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NET) with high disease burden

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Hungary Italy The Netherlands Poland +1

  • Efficacy and Safety Study of Paltusotine for Adults with Carcinoid Syndrome due to Well-Differentiated Neuroendocrine Tumors

    Recruiting

    3 1
    Investigated Drugs:
    Belgium Denmark France Germany Ireland Italy +4

  • Study of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium Denmark France Germany Italy The Netherlands +5

  • Study on the Safety and Effectiveness of Trastuzumab Deruxtecan vs. Palbociclib-Based Drug Combination for Advanced HR-Positive, HER2-Low Breast Cancer Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Germany Italy The Netherlands +3

  • Study on Managing Heart Attack Risk with Icosapent Ethyl and Drug Combination for Patients at High Risk of Another Heart Attack

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany Poland

  • Study on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer

    Recruiting

    4 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria France Germany Hungary Italy +3

  • Study on Rituximab for Adults with Relapsing Steroid-Sensitive Nephrotic Syndrome

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland